Early determinants of atherosclerosis in paediatric systemic lupus erythematosus

被引:0
|
作者
Boros, C. A. [1 ,6 ,9 ]
Bradley, T. J. [2 ,9 ]
Cheung, M. M. H. [2 ,9 ]
Bargman, J. M. [5 ,7 ]
Russell, J. L. [2 ,9 ]
McCrindle, B. W. [2 ,9 ]
Adeli, K. [3 ]
Hamilton, J. [4 ,9 ]
Silverman, E. D. [1 ,6 ,8 ,9 ]
机构
[1] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Toronto Gen Hosp, Div Nephrol, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[9] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
vascular testing; cardiovascular risk factors; lipids; insulin resistance; LOW-DENSITY-LIPOPROTEIN; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-PERFUSION; YOUNG-ADULTS; WOMEN; CHILDREN; DISEASE; HOMOCYSTEINE; PROGRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess traditional and non-traditional cardiovascular risk factors and to determine the prevalence and correlates of early vascular markers of atherosclerosis in paediatric systemic lupus erythematosus (pSLE). Methods Fifty-four adolescents with pSLE had cardiovascular risk factor assessment, disease activity and vascular testing including carotid intima-media thickness (CIMT), flow-mediated dilatation (FMD), arterial stiffness measures, and myocardial perfusion studies. Results The traditional risk factors of hypertension, elevated triglycerides, apolipoprotein B, haemoglobin AI c and insulin levels and non-traditional risk factors of elevated homocysteine and fibrinogen were present (all p<0.001). Some arterial stiffness measures, central pulse wave velocity and characteristic impedance were elevated (p<0.001), but CIMT, FMD and myocardial perfusion were normal. Cumulative prednisone dose correlated with total cholesterol (r=0.5790, p<0.001) and elevated LDL-C (r=0.4488, p=0.0012). Hydroxychloroquine treatment correlated negatively with total cholesterol (r=-0.4867, p=0.0002), LDL-C (r=-0.4805, p=0.0002) and apolipoprotein B (r=-0.4443, p=0.0011). In multivariate analysis LDL-C correlated with cumulative prednisone dose and negatively with hydroxychloroquine treatment (R-2=0.40, p<0.001). Conclusions An increased burden of traditional and non-traditional risk factors and early evidence of insulin resistance and increased central arterial stiffness were present in paediatric SLE. Disease-specific and therapy-related factors are likely modifying these cardiovascular risk profiles warranting prospective longitudinal studies.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 50 条
  • [21] How to predict subclinical atherosclerosis in systemic lupus erythematosus
    Zardi, Enrico M.
    Afeltra, Antonella
    RHEUMATOLOGY, 2011, 50 (05) : 821 - 823
  • [22] Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis
    Chung, C. P.
    Long, A. G.
    Solus, J. F.
    Rho, Y. H.
    Oeser, A.
    Raggi, P.
    Stein, C. M.
    LUPUS, 2009, 18 (09) : 799 - 806
  • [23] Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
    Teixeira, Vitor
    Tam, Lai-Shan
    FRONTIERS IN MEDICINE, 2018, 4
  • [24] Predictors of carotid atherosclerosis in systemic lupus erythematosus
    Maksimowicz-McKinnon, Kathleen
    Magder, Laurence S.
    Petri, Michelle
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2458 - 2463
  • [25] Apolipoprotein-Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Systemic Lupus Erythematosus
    Kiani, Adnan N.
    Fang, Hong
    Akhter, Ehtisham
    Quiroga, Carmen
    Simpson, Nancy
    Alaupovic, Petar
    Magder, Laurence S.
    Petri, Michelle
    ARTHRITIS CARE & RESEARCH, 2015, 67 (03) : 442 - 446
  • [26] Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus
    Chung, C. P.
    Solus, J. F.
    Oeser, A.
    Li, C.
    Raggi, P.
    Smith, J. R.
    Stein, C. M.
    LUPUS, 2014, 23 (09) : 876 - 880
  • [27] Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
    Icli, Abdullah
    Cure, Erkan
    Cure, Medine Cumhur
    Uslu, Ali Ugur
    Balta, Sevket
    Mikhailidis, Dimitri P.
    Ozturk, Cengiz
    Arslan, Sevket
    Sakiz, Davut
    Sahin, Muhammed
    Kucuk, Adem
    ANGIOLOGY, 2016, 67 (08) : 749 - 755
  • [28] Factors associated with the appearance of subclinical atherosclerosis in systemic lupus erythematosus
    Hernandez Muniz, Yanileydys
    Dedieu Montero, Diosmary
    Pozo Abreu, Silvia Maria
    Carrillo Reyes, Carlos
    Mederos Castellanos, Ailyn
    REVISTA CUBANA DE REUMATOLOGIA, 2022, 24 (01):
  • [29] 17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr-/- mice
    Shelton, K. A.
    Cline, J. M.
    Cann, J. A.
    ATHEROSCLEROSIS, 2013, 227 (02) : 228 - 235
  • [30] Assessment of Arterial Stiffness and Biochemical Markers in Systemic Lupus Erythematosus in the Diagnosis of Subclinical Atherosclerosis
    Blachut, Dominika
    Przywara-Chowaniec, Brygida
    Mazurkiewicz, Michalina
    Tomasik, Andrzej
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):